Efficacy of Two Streptokinase Formulations in Acute Myocardial Infarction: A Double-Blind Randomized Clinical Trial

Efficacy of Two Streptokinase Formulations in Acute Myocardial Infarction: A Double-Blind Randomized Clinical Trial

Show other versions (1)

Background: We sought to evaluate the efficacy and safety of the different trade forms of streptokinase available in our country, namely Heberkinasa (Heberbiotec, Havana, Cuba) and Streptase (Aventis Behring GmbH, Marburg, Germany). Methods: We conducted a double-blind randomized clinical trial to...

Full description

Bibliographic Details
Main Authors: Mojtaba Salarifar, Saeed Sadeghian, Ali Abbasi, Gholamreza Davoodi, Alireza Amirzadegan, Seyed Kianoosh Hosseini, Navid Paydari, Aida Biria, Parisa Moemeni
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2009-01-01
Series:Journal of Tehran University Heart Center
Subjects:
Streptokinase
Thrombolytic therapy
Myocardial infarction
Online Access:https://jthc.tums.ac.ir/index.php/jthc/article/view/116

Internet

https://jthc.tums.ac.ir/index.php/jthc/article/view/116

Similar Items